Literature DB >> 21644931

Association of major histocompatibility complex class I chain-related gene A microsatellite polymorphism and hepatocellular carcinoma in South China Han population.

X Jiang1, Y Zou, Z Huo, P Yu.   

Abstract

The major histocompatibility complex (MHC) class I-related gene A (MICA) is a stress-induced antigen and plays a key role in anti-infectious and anti-tumoral immune responses. In this study, we investigated the MICA transmembrane polymorphism in hepatocellular carcinoma (HCC) patients in South China Han population. We found that the MICA-A5.1 polymorphism, which gives rise to a truncated protein, was increased in HCC patients compared with healthy controls (P(c) = 0.036). Furthermore, we found that HCC patients with MICA-A5.1 polymorphism had higher serum levels of soluble MICA (sMICA). These results suggest that MICA-A5.1 polymorphism is associated with HCC patients in South China Han population and the MICA-A5.1 polymorphism may contribute to the development of HCC by promoting the release of sMICA to evade tumor immunosurveillance.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21644931     DOI: 10.1111/j.1399-0039.2011.01693.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  11 in total

1.  MICA polymorphisms and cancer risk: a meta-analysis.

Authors:  Mengyao Ji; Jun Wang; Lei Yuan; Yunting Zhang; Jixiang Zhang; Weiguo Dong; Xiulan Peng
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  A Genome-Wide Association Study Identifies Two Novel Susceptible Regions for Squamous Cell Carcinoma of the Head and Neck.

Authors:  Hongliang Liu; Jian Wang; Robert Yu; Sanjay Shete; Erich M Sturgis; Guojun Li; Kristina R Dahlstrom; Zhensheng Liu; Christopher I Amos; Qingyi Wei
Journal:  Cancer Res       Date:  2020-04-10       Impact factor: 12.701

Review 3.  MICA SNPs and the NKG2D system in virus-induced HCC.

Authors:  Kaku Goto; Naoya Kato
Journal:  J Gastroenterol       Date:  2014-10-01       Impact factor: 7.527

4.  A variant upstream of HLA-DRB1 and multiple variants in MICA influence susceptibility to cervical cancer in a Swedish population.

Authors:  Dan Chen; Joanna Hammer; David Lindquist; Annika Idahl; Ulf Gyllensten
Journal:  Cancer Med       Date:  2014-01-07       Impact factor: 4.452

Review 5.  Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks.

Authors:  Antje Isernhagen; Dörthe Malzahn; Heike Bickeböller; Ralf Dressel
Journal:  Front Immunol       Date:  2016-12-12       Impact factor: 7.561

6.  Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study.

Authors:  Guillaume Onyeaghala; John Lane; Nathan Pankratz; Heather H Nelson; Bharat Thyagarajan; Bruce Walcheck; Kristin E Anderson; Anna E Prizment
Journal:  PLoS One       Date:  2019-06-05       Impact factor: 3.240

7.  Single nucleotide polymorphism of rs2596542 and the risk of hepatocellular carcinoma development: A meta-analysis.

Authors:  Xue-Jun Kuang; Dun-Chang Mo; Yan Qin; Bhavesh K Ahir; Jian-Jun Wang; Zhao Peng; Zu-Liang Deng
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

8.  Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patients.

Authors:  Xiaoxin Jiang; Ju-Fang Huang; Zhi Huo; Qiuqui Zhang; Yan Jiang; Xiaoping Wu; Yanwen Li; Guanmin Jiang; Leping Zeng; Xiao-Xin Yan; Ping Yu; Renxian Cao
Journal:  BMC Immunol       Date:  2012-11-26       Impact factor: 3.615

9.  The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.

Authors:  Antje Isernhagen; Daniela Schilling; Sebastian Monecke; Pranali Shah; Leslie Elsner; Lutz Walter; Gabriele Multhoff; Ralf Dressel
Journal:  Immunogenetics       Date:  2015-11-19       Impact factor: 2.846

10.  High-Throughput MICA/B Genotyping of Over Two Million Samples: Workflow and Allele Frequencies.

Authors:  Anja Klussmeier; Carolin Massalski; Kathrin Putke; Gesine Schäfer; Jürgen Sauter; Daniel Schefzyk; Jens Pruschke; Jan Hofmann; Daniel Fürst; Raphael Carapito; Seiamak Bahram; Alexander H Schmidt; Vinzenz Lange
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.